The Institute of Plant Based Medicine Announces Two Exciting Weight Loss Programs That are Currently Pending FDA Approval
NEWPORT BEACH, Calif. - July 5, 2022 - PRLog -- The Institute of Plant-Based Medicine, a trusted and respected name in lifestyle medicine, specializing in a wide range of medical specialties announces two exciting weight loss programs that are currently pending FDA approval. The forecast for these approvals looks highly likely and very promising. The programs discussed here are the ESG (Endoscopic Sleeve Gastroplasty)
The once-a-week injectable medication known as Mounjaro helps to better regulate blood sugar levels. Currently, it is indicated for use in patients with type 2 diabetes, but it shows great promise as a weight-loss drug as well, and as such is pending FDA approval. Clinical trials found that doses of Mounjaro (tirzepatide)
Endoscopic Sleeve Gastroplasty (ESG) offers effective weight loss and is the latest weight loss concept that uses endoscopic suturing procedures to in-effect shrink the stomach to better control food intake. It does this without the need for surgery and results in no external incisions, minimal complications, and a rapid recovery. ESG is a safe and effective unique alternative to weight loss for those who have not been able to lose weight in the past. Besides helping to lose weight, it reduces the risks of high blood pressure, type II diabetes and any lipid abnormalities. Encouraging outcomes are also expected for many other conditions such as heart disease, osteoarthritis, kidney failure and cancer as well as stroke. It is vital that the patient know that ESG is not effective unless there are ongoing lifestyle changes, especially regarding diet. Regular follow-up appointments are also essential to long term success. The following describe a typical good candidate for the procedure: A body mass index of 30-40, no history of eating disorders such as bulimia, no indications of uncontrolled gastrointestinal bleeding and no hemophilia or currently on blood thinners.
The Institute of Plant-Based Medicine is confident that the FDA will in fact approve these procedures and medications to greatly enhance weight loss success in patients who have struggled for many years with obesity and excess weight. The Institute prides itself on staying at the cutting edge of the latest technology, science and the procedures that help people enjoy a better quality of life through a plant-based diet along with modern science and medical advances. This recent announcement with regard to two new exciting weight loss programs that are currently pending FDA approval is just one more key indicator that the Institute of Plant-Based Medicine will continue to be an advocate for the patient especially when it comes to weight loss modalities, programs and the latest procedures.
About The Institute of Plant Based Medicine
The Institute of Plant-Based Medicine is the first multi-specialty plant-based medical clinic found anywhere in the world today. The Institute of Plant Based Medicine (IOPBM) was first inspired, founded, and ultimately developed in early 2020 by Dr. Angie Sadeghi along with her support team of experienced and skilled practitioners. The team understood that there was a clear and obvious disconnect in the merging of medical knowledge with nutritional knowledge in the world of health, wellness, and nutrition. As individual practitioners the team realized that a plant-based diet approach was the most beneficial for patients that have a wide array of conditions, diseases, and illnesses. As such, the ability to consult and draw upon different specialties within one group would solidify the patient's health in a more synergistic and most beneficial way.
Dr. Angie Sadeghi